Veuillez utiliser cette adresse pour citer ce document : http://dspace1.univ-tlemcen.dz/handle/112/958
Titre: The Complementarity Effect for Cdc25 Phosphatase Inhibitors
Auteur(s): SOUFI, Wassila
MERAD, Meriem
BOUKLI, Faïza
GHALEM, Saïd
Mots-clés: Cancer
Cdc25 Phosphatase
Molecular Modeling (MM, DM, and Docking)
Naphtoquinone
Date de publication: 30-mai-2011
Résumé: Cdc25 phosphatase have been regarded as attractive drug targets for anticancer therapies due to the correlation of their over expression with a wide variety of cancers. They are key regulators of cell cycle progression and play a central role in the checkpoint response to DNA damage. The role of Cdc25 s in cancer has become increasingly evident in recent years. More than 20 studies of patient samples are from diverse cancers show significant overexpression of Cdc25 with frequent correlation to clinical outcome. Recent screening and design efforts have yielded novel classes of inhibitors that show specificity for the Cdc25 s over other phosphatases and cause cell cycle arrest in vivo. Until now, quinone derivatives are among the most efficient inhibitors of Cdc25 phosphatase activity. Our research objective is to study the inhibition of the phosphathase Cdc25 through the molecular modeling methods.
URI/URL: http://dspace.univ-tlemcen.dz/handle/112/958
Collection(s) :Articles internationaux

Fichier(s) constituant ce document :
Fichier Description TailleFormat 
The_Complementarity_Effect_for_Cdc25_Phosphatase_Inhibitors.pdf68,49 kBAdobe PDFVoir/Ouvrir


Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.